---
figid: PMC3842443__jcav04p0736g002
figtitle: Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized
  Therapy
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3842443
filename: jcav04p0736g002.jpg
figlink: /pmc/articles/PMC3842443/figure/F2/
number: F2
caption: TKI; tyrosine kinase inhibitors, S6K1; 40S ribosomal protein S6 kinase, IRS1/2;
  insulin receptor substrate, 4E-BP1; 4E binding protein-1, Akt; protein kinase B,
  mTOR; mammalian target of rapamycin, STRAD; Ste20-like adaptor protein, TSC; tuberous
  sclerosis complex, AMPK; adenosine mono-phosphate-activated protein kinase, LKB1;
  liver kinase B1, HGF; hepatocyte growth factor, MET; mesenchymal-epithelial transition
  factor, Rho; RAS homolog gene family, Rac1; RAS-related C3 botulinum toxin substrate
  1, CDC42; cell division cycle 42, Rheb; Ras homolog enriched in brain, MO25; monoclonal
  antibody, ERBB3; v-erb-b2 erythroblastic leukemia viral oncogene homolog 3. Growth
  factors when activated trigger the mTOR-signaling pathway finally resulting in increased
  cell growth, gene transcription and cell proliferation.
papertitle: Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of
  Individualized Therapy.
reftext: Kalliopi Domvri, et al. J Cancer. 2013;4(9):736-754.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9634423
figid_alias: PMC3842443__F2
figtype: Figure
redirect_from: /figures/PMC3842443__F2
ndex: 1f5f5e2f-ded7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3842443__jcav04p0736g002.html
  '@type': Dataset
  description: TKI; tyrosine kinase inhibitors, S6K1; 40S ribosomal protein S6 kinase,
    IRS1/2; insulin receptor substrate, 4E-BP1; 4E binding protein-1, Akt; protein
    kinase B, mTOR; mammalian target of rapamycin, STRAD; Ste20-like adaptor protein,
    TSC; tuberous sclerosis complex, AMPK; adenosine mono-phosphate-activated protein
    kinase, LKB1; liver kinase B1, HGF; hepatocyte growth factor, MET; mesenchymal-epithelial
    transition factor, Rho; RAS homolog gene family, Rac1; RAS-related C3 botulinum
    toxin substrate 1, CDC42; cell division cycle 42, Rheb; Ras homolog enriched in
    brain, MO25; monoclonal antibody, ERBB3; v-erb-b2 erythroblastic leukemia viral
    oncogene homolog 3. Growth factors when activated trigger the mTOR-signaling pathway
    finally resulting in increased cell growth, gene transcription and cell proliferation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CDC42
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - RAC1
  - RNASE1
  - HGF
  - IL6
  - SOS1
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ERBB3
  - STRADA
  - STK11
  - CAB39
  - TSC2
  - TSC1
  - CCL26
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - EIF4EBP1
  - RHEB
  - RHEBP1
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - RPTOR
  - IRS1
  - RPS6KB1
---
